Citation Impact
Citing Papers
Management of Helicobacter pylori infection—the Maastricht V/Florence Consensus Report
2016 Standout
Management of Helicobacter pylori infection—the Maastricht IV/ Florence Consensus Report
2012 Standout
Helicobacter pylori in gastro-oesophageal reflux disease: causal agent, independent or protective factor?
1997
Tubular phenotypic change in progressive tubulointerstitial fibrosis in human glomerulonephritis
2001
Efficacy of two different dosage regimens of omeprazole, amoxycillin and metronidazole for the cure of Helicobacter pylori infection
1999
Disruption of tissue-type plasminogen activator gene in mice reduces renal interstitial fibrosis in obstructive nephropathy
2002
Bone Marrow–Derived Cells Do Not Contribute Significantly to Collagen I Synthesis in a Murine Model of Renal Fibrosis
2006 StandoutNobel
Epithelial-mesenchymal transition and its implications for fibrosis
2003 Standout
Cancer burden in the year 2000. The global picture
2001 Standout
Hepatocyte Growth Factor Suppresses Renal Interstitial Myofibroblast Activation and Intercepts Smad Signal Transduction
2003
Evidence that fibroblasts derive from epithelium during tissue fibrosis
2002 Standout
Cellular and molecular mechanisms of fibrosis
2007 Standout
Medicinal plants and antimicrobial activity
2005 Standout
Hepatocyte Growth Factor Gene Therapy and Angiotensin II Blockade Synergistically Attenuate Renal Interstitial Fibrosis in Mice
2002
Metabolic benefits of dietary prebiotics in human subjects: a systematic review of randomised controlled trials
2013
Enhancing Compliance Not A Prerequisite for Effective Eradication of Helicobacter Pylori : The Help Study
1999
TGF-β: the master regulator of fibrosis
2016 Standout
Expert consensus document: The International Scientific Association for Probiotics and Prebiotics (ISAPP) consensus statement on the definition and scope of prebiotics
2017 Standout
Dissection of Key Events in Tubular Epithelial to Myofibroblast Transition and Its Implications in Renal Interstitial Fibrosis
2001 Standout
Abnormal p38 mitogen-activated protein kinase signalling in human and experimental diabetic nephropathy
2004
The Human Intestinal Microbiome in Health and Disease
2016 Standout
Kyoto global consensus report onHelicobacter pylorigastritis
2015 Standout
The global health burden of infection‐associated cancers in the year 2002
2006 Standout
Meta‐analysis: the effect of antibiotic resistance status on the efficacy of triple and quadruple first‐line therapies for Helicobacter pylori
2007
Mechanisms of probiosis and prebiosis: considerations for enhanced functional foods
2009
Evaluation of Experimental Therapeutics in a New Mouse Model ofHelicobacter felisUtilizing 16S rRNA Polymerase Chain Reaction for Detection
1997
Complex networks orchestrate epithelial–mesenchymal transitions
2006 Standout
Glomerular epithelial–myofibroblast transdifferentiation in the evolution of glomerular crescent formation
1999
The MACH2 study: Role of omeprazole in eradication of Helicobacter pylori with 1-week triple therapies
1999
Modulation of the fecal microflora profile and immune function by a novel trans-galactooligosaccharide mixture (B-GOS) in healthy elderly volunteers
2008
Ultrastructural characteristics of diabetic nephropathy
2000
Pharmacogenomics of proton pump inhibitors
2004
Transforming growth factor-β regulates tubular epithelial-myofibroblast transdifferentiation in vitro
1999
Short-chain fatty acids, prebiotics, synbiotics, and systemic inflammation: a systematic review and meta-analysis
2017
Chronic Renal Allograft Dysfunction
2004
Pathologic Classification of Diabetic Nephropathy
2010 Standout
Metronidazole
1997
Eradication ofH. pyloriwith Pantoprazole, Clarithromycin, and Metronidazole in Duodenal Ulcer Patients: A Head‐to‐Head Comparison Between Two Regimens of Different Duration
2000
Ageing of the human metaorganism: the microbial counterpart
2011
Fibroblast Differentiation in Wound Healing and Fibrosis
2007
Morphologic Changes in the Peritoneal Membrane of Patients with Renal Disease
2002 Standout
Effect of Pretreatment Antibiotic Resistance to Metronidazole and Clarithromycin on Outcome of Helicobacter pylori Therapy
2000
Modelling cost-effectiveness of Helicobacter pylori screening to prevent gastric cancer: a mandate for clinical trials
1996
The HOMER Study: The Effect of Increasing the Dose of Metronidazole When Given with Omeprazole and Amoxicillin to Cure Helicobacter pylori Infection
2000
Ageing and gut microbes: Perspectives for health maintenance and longevity
2012
Epithelial-mesenchymal transition of tubular epithelial cells in human renal biopsies
2002
The role of short-chain fatty acids in microbiota–gut–brain communication
2019 Standout
Eradication of Helicobacter pylori Using One‐week Triple Therapies Combining Omeprazole with Two Antimicrobials: The MACH I Study
1996
Systemic sclerosis: a prototypic multisystem fibrotic disorder
2007 Standout
Prevalence of Antibiotic Resistance in Helicobacter pylori: A Systematic Review and Meta-analysis in World Health Organization Regions
2018 Standout
Mechanisms of fibrosis: therapeutic translation for fibrotic disease
2012 Standout
H pylori antibiotic resistance: prevalence, importance, and advances in testing
2004 Standout
Advanced Glycation End Products Induce Tubular Epithelial-Myofibroblast Transition through the RAGE-ERK1/2 MAP Kinase Signaling Pathway
2004
Role of apoptosis and transforming growth factor β1 in fibroblast selection and activation in systemic sclerosis
2000
Helicobacter pyloriInfection
2002 Standout
Gelatinase A (MMP-2) Is Necessary and Sufficient for Renal Tubular Cell Epithelial-Mesenchymal Transformation
2003
Eradication of Helicobacter pylori by 7‐Day Triple‐Therapy Regimens Combining Pantoprazole with Clarithromycin, Metronidazole, or Amoxicillin in Patients with Peptic Ulcer Disease: Results of Two Double‐Blind, Randomized Studies
2003
DNA breakage due to metronidazole treatment
2001
Clinical Relevance of resistant strains of Helicobacter pylori: a review of current data
1998
The basics of epithelial-mesenchymal transition
2009 Standout
Nrf2–Keap1 defines a physiologically important stress response mechanism
2004 Standout
Renal fibroblast-like cells in Goodpasture syndrome rats
2001
Fibroblasts in cancer
2006 Standout
Cachexia and aging: An update based on the fourth international cachexia meeting
2009
Mesenchymal transition in kidney collecting duct epithelial cells
2008
Cytochrome P450 enzymes in drug metabolism: Regulation of gene expression, enzyme activities, and impact of genetic variation
2013 Standout
Interventions to Enhance Patient Adherence to Medication Prescriptions
2002 Standout
Management ofHelicobacter pylorieradication – the influence of structured counselling and follow‐up
2002
Immunosuppressive Drugs for Kidney Transplantation
2004 Standout
Second‐line treatment for failure to eradicate Helicobacter pylori: a randomized trial comparing four treatment strategies
2003
Review article: ‘true’ re‐infection of Helicobacter pylori after successful eradication – worldwide annual rates, risk factors and clinical implications
2008
Current concepts in the management of Helicobacter pylori infection: the Maastricht III Consensus Report
2006 Standout
Bifidobacteria can protect from enteropathogenic infection through production of acetate
2011 StandoutNature
Interleukin-1 induces tubular epithelial-myofibroblast transdifferentiation through a transforming growth factor-β1-dependent mechanism in vitro
2001
Blockage of Tubular Epithelial to Myofibroblast Transition by Hepatocyte Growth Factor Prevents Renal Interstitial Fibrosis
2002
One week triple therapy for Helicobacter pylori : a multicentre comparative study
1997
Positive Result by Serology Indicates Active Helicobacter pylori Infection in Patients with Atrophic Gastritis
1998
Direct evidence that sulfhydryl groups of Keap1 are the sensors regulating induction of phase 2 enzymes that protect against carcinogens and oxidants
2002 Standout
Role of Nrf2 in Oxidative Stress and Toxicity
2013 Standout
Vascular and Interstitial Changes in the Peritoneum of Capd Patients with Peritoneal Sclerosis
1999
Effects of Probiotics, Prebiotics, and Synbiotics on Human Health
2017 Standout
Fibroblast heterogeneity in physiological conditions and fibrotic disease
1999
Eradication ofHelicobacter pylori
1996
Evolution of the immune system in humans from infancy to old age
2015 Standout
Cell Survival Responses to Environmental Stresses Via the Keap1-Nrf2-ARE Pathway
2006 Standout
Interventions for enhancing medication adherence
2008 Standout
Evidence that fibroblasts derive from epithelium during tissue fibrosis
2002 Standout
Effect of ornidazole and clarithromycin resistance on eradication of Helicobacter pylori in peptic ulcer disease
2000
Click Chemistry-Facilitated Structural Diversification of Nitrothiazoles, Nitrofurans, and Nitropyrroles Enhances Antimicrobial Activity against Giardia lamblia
2017 StandoutNobel
Riddle of Biofilm Resistance
2001 Standout
Tubular epithelial-myofibroblast transdifferentiation in progressive tubulointerstitial fibrosis in 5/6 nephrectomized rats
1998
Introduction to the human gut microbiota
2017 Standout
Pathophysiology of Type 2 Diabetes Mellitus
2020 Standout
Pathogenesis ofHelicobacter pyloriInfection
2006 Standout
Interventions for enhancing medication adherence
2014 Standout
BIOLOGY AND BIOCHEMISTRY OF GLUCOSINOLATES
2006 Standout
The KEAP1-NRF2 System: a Thiol-Based Sensor-Effector Apparatus for Maintaining Redox Homeostasis
2018 Standout
Wound Healing: A Cellular Perspective
2018 Standout
Synbiotic consumption changes the metabolism and composition of the gut microbiota in older people and modifies inflammatory processes: a randomised, double-blind, placebo-controlled crossover study
2013
Sulforaphane inhibits extracellular, intracellular, and antibiotic-resistant strains ofHelicobacter pyloriand prevents benzo[a]pyrene-induced stomach tumors
2002
Activities of Garlic Oil, Garlic Powder, and Their Diallyl Constituents against Helicobacter pylori
2000
2013
Epithelial-mesenchymal transition and its implications for fibrosis
2003 Standout
Transmission of Helicobacter pylori
1999
Sarcopenia: European consensus on definition and diagnosis
2010 Standout
Blockade of Endothelial-Mesenchymal Transition by a Smad3 Inhibitor Delays the Early Development of Streptozotocin-Induced Diabetic Nephropathy
2010
Epidemiology of gastric cancer
2006 Standout
Disruption of tissue-type plasminogen activator gene in mice reduces renal interstitial fibrosis in obstructive nephropathy
2002
Works of C. Brown being referenced
Rapid eradication of Helicobacter pylori infection
1995
Myofibroblasts and the progression of diabetic nephropathy
1997
Helicobacter pylori eradication in patients with peptic ulcer disease: clinical consequences and financial implications
1994
<italic>Helicobacter pylori eradication</italic>: efficacy and side effect profile of a combination of omeprazole, amoxycillin and metronidazole compared with four alternative regimens
1993
Systemic inflammatory markers in older persons: the effect of oral nutritional supplementation with prebiotics.
2008